UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Lancet neurology, 2016-06, Vol.15 (7), p.673-684

2016

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

Molecular psychiatry, 2021-02, Vol.26 (2), p.429-442

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

Clinical chemistry and laboratory medicine, 2016-10, Vol.54 (10), p.1655

2016

Link zum Volltext

Verfügbarkeit prüfen

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

Scientific reports, 2016-11, Vol.6 (1), p.36791-36791, Article 36791

2016

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease

Brain (London, England : 1878), 2015-11, Vol.138 (Pt 11), p.3373-3385

2015

Link zum Volltext

Verfügbarkeit prüfen

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

Neurology, 2016-09, Vol.87 (13), p.1329

2016

Link zum Volltext

Verfügbarkeit prüfen

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease

Alzheimer's research & therapy, 2018-07, Vol.10 (1), p.71-71, Article 71

2018

Link zum Volltext

Verfügbarkeit prüfen

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

EBioMedicine, 2016-01, Vol.3 (C), p.135-140

2016

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury

Scientific reports, 2020-10, Vol.10 (1), p.18075-18075, Article 18075

2020

Link zum Volltext

Verfügbarkeit prüfen

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum

Alzheimer's & dementia, 2021-03, Vol.17 (3), p.431-445

2021

Link zum Volltext

Verfügbarkeit prüfen

Dementia and CSF‐biomarkers for Alzheimer's disease predict mortality after acute hip fracture

Acta anaesthesiologica Scandinavica, 2020-01, Vol.64 (1), p.93-103

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

PloS one, 2013, Vol.8 (6), p.e66381-e66381

2013

Link zum Volltext

Verfügbarkeit prüfen

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2016, Vol.3 (1), p.98-102

2016

Link zum Volltext

Verfügbarkeit prüfen

C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease

Alzheimer's & dementia, 2015-12, Vol.11 (12), p.1461-1469

2015

Link zum Volltext

Verfügbarkeit prüfen

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

Multiple sclerosis, 2015-04, Vol.21 (5), p.550-561

2015

Link zum Volltext

Verfügbarkeit prüfen

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

Current pharmaceutical design, 2011-08, Vol.17 (25), p.2594

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football

Medicine and science in sports and exercise, 2016-06, Vol.48 (6), p.974-982

2016

Link zum Volltext

Verfügbarkeit prüfen

Harmonization and standardization of biofluid-based biomarker measurements for AT(N) classification in Alzheimer's disease

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2023-07, Vol.15 (3), p.e12465-e12465

2023

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

Alzheimer's research & therapy, 2015-07, Vol.7 (1), p.40-40, Article 40

2015

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease

Journal of Alzheimer's disease, 2020-01, Vol.75 (3), p.937

2020

Link zum Volltext

Verfügbarkeit prüfen

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg

Alzheimer's research & therapy, 2020-02, Vol.12 (1), p.20-20, Article 20

2020

Link zum Volltext

Verfügbarkeit prüfen

Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus

Fluids and barriers of the CNS, 2021-05, Vol.18 (1), p.23-23, Article 23

2021

Link zum Volltext

Verfügbarkeit prüfen

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system

PloS one, 2012-02, Vol.7 (2), p.e31084-e31084

2012

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

Journal of Neural Transmission, 2012-07, Vol.119 (7), p.789-797

2012

Link zum Volltext

Verfügbarkeit prüfen

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid

International journal of alzheimer's disease, 2010, Vol.2010, p.1-11

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(367)
Mit Volltextzugriff
(326)

Publikationsform

Artikel
(372)
Tagungsberichte
(3)

Sprache

Englisch
(375)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Life Sciences & Biomedicine
(171)
Humans
(152)
Neurosciences
(145)
Neurovetenskaper
(118)
Neurology
(114)
Cerebrospinal Fluid
(110)
Neurosciences & Neurology
(109)
Male
(107)
Female
(106)
Alzheimer's Disease
(104)
Biomarkers
(80)
Medicin Och Hälsovetenskap
(76)
Aged
(74)
Clinical Neurology
(72)
Middle Aged
(70)
Biomarkers - Cerebrospinal Fluid
(64)
Amyloid Beta-Peptides - Cerebrospinal Fluid
(58)
Alzheimer Disease - Cerebrospinal Fluid
(55)
Medical And Health Sciences
(52)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum

Dementia and CSF‐biomarkers for Alzheimer's disease predict mortality after acute hip fracture

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders

C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football

Harmonization and standardization of biofluid-based biomarker measurements for AT(N) classification in Alzheimer's disease

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg

Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid

Suchergebnisse filtern